Phorbiplatin, a Highly Potent Pt(IV) Antitumor Prodrug That Can Be Controllably Activated by Red Light-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phorbiplatin, a Highly Potent Pt(IV) Antitumor Prodrug That Can Be Controllably Activated by Red Light

Published:2019-12 Issue:12 Volume:5 Page:3151-3165
ISSN:2451-9294
Container-title:Chem
language:en
Short-container-title:Chem

Author:

Wang Zhigang,Wang Na,Cheng Shun-Cheung,Xu Kai,Deng Zhiqin,Chen Shu,Xu Zoufeng,Xie Kai,Tse Man-Kit,Shi Peng,Hirao Hajime,Ko Chi-Chiu,Zhu Guangyu

Funder

Hong Kong Research Grants Council

National Natural Science Foundation of China

City University of Hong Kong

Science Technology and Innovation Committee of Shenzhen Municipality

Shenzhen University

Publisher

Elsevier BV

Subject

Materials Chemistry,Biochemistry (medical),General Chemical Engineering,Environmental Chemistry,Biochemistry,General Chemistry

Reference73 articles.

1. Physical energy for drug delivery; poration, concentration and activation;Lakshmanan;Adv. Drug Deliv. Rev.,2014

2. Designing metal-contained enzyme mimics for prodrug activation;Du;Adv. Drug Deliv. Rev.,2017

3. Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety;Zhu;Proc. Natl. Acad. Sci. USA,2013

4. An activatable prodrug for the treatment of metastatic tumors;Kim;J. Am. Chem. Soc.,2014

5. Hypoxia-activated prodrugs: paths forward in the era of personalised medicine;Hunter;Br. J. Cancer,2016

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semiconducting polymer nanoprodrugs enable tumor-specific therapy via sono-activatable ferroptosis;Biomaterials;2025-01

2. Pt(IV) Prodrug Photoactivation: A Promising Strategy for Cancer Therapy;Current Protein & Peptide Science;2024-12

3. Locally unlocks prodrugs by radiopharmaceutical in tumor for cancer therapy;Science Bulletin;2024-09

4. Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy;Smart Molecules;2024-08-29

5. Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment;Frontiers in Pharmacology;2024-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3